Advertisement

Topics

Companies Related to "Study of Genetic Factors Other Than CYP2C9 and VKORC1 That Influence Warfarin Dose Requirements in a South-east Asian Population" [Most Relevant Company Matches] RSS

18:03 EDT 21st October 2018 | BioPortfolio

Here are the most relevant search results for "Study of Genetic Factors Other Than CYP2C9 and VKORC1 That Influence Warfarin Dose Requirements in a South-east Asian Population" found in our extensive corporate database of over 50,000 company records.

Showing "Study Genetic Factors Other Than CYP2C9 VKORC1 That" Companies 1–25 of 865

Extremely Relevant

PGXL Laboratories, LLC

A privately-owned business located in Louisville, Kentucky, PGXL Laboratories was the first lab in the country CLIA-certified specifically to conduct pharmacogenetic tests. It offers pharmacogenetic testing and interpretive services, and developed one of the first commercial CYP2C9/VKORC1 tests for accurate anticoagulant dosing. Along with its clinical practice, PGXL performs contract research for...


Relevant

Genetic Analysis

Genetic Analysis has developed and launched the first gene-based routine test for the mapping and diagnosis of diseases related to dysbiosis and imbalances in the bacteria in the digestive system. The company markets the GA-map™ technology to three market segments: commercial routine testing, pharma companies and the research market. Genetic Analysis ...

CENTOGENE

CENTOGENE unlocks the power of genetic insights to improve the quality of life of patients with rare genetic diseases. We achieve this through knowledge created by our worldwide diagnostic testing services incorporating global diversity, the world’s leading proprietary human genetic interpretation database, CentoMD® and solutions for pharmaceutical...


Population Genetics

Harnessing The Power of Populations™ Population Genetics’ approach takes the process of genetic analysis one step further. It enables the elaboration and testing of distinct hypotheses focused on both contiguous and non-contiguous regions of the genome. Whether these have been identified by other technologies such as investigation of gene expression levels, copy number variation, p...

Color Genomics

Color Genomics provides a high-quality, physician-ordered, genetic test for 19 genes related to breast and ovarian cancer risk, including BRCA1 and BRCA2. The Color Test includes support for physicians, as well as genetic counseling as part of every order. Color’s goal is to expand physician-supported access to genetic information for breast and ovarian ...

Genetic Technologies Limited

Genetic Technologies was an early pioneer in recognizing important new applications for “non-coding” DNA (Deoxyribonucleic Acid). The Company has since been granted patents in 24 countries around the world, securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all spec...

Natera, Inc.

Natera is a genetic testing company that has developed a proprietary bioinformatics technology (Parental Support) to deliver accurate and comprehensive high throughput testing for reproductive indications from tiny quantities of DNA – as small as that from a single cell. Natera operates a CLIA laboratory in Redwood City, Calif., providing a host of pr...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intell...

Oncogene Research Products

Assays, ELISAs, antibodies, growth factors, receptors, ligands peptides, probes, hormones, neurotoxins, and enzymes for the study of angiogenesis, apoptosis, cancer, cell cycle/proliferation, proteases, signal transduction, neuroscience.cell biology relat

Caprologics

Capralogics has manufactured a variety of novel polyclonal antibodies against Cell Membrane Receptors, Nuclear Components, Apoptosis Factors, Neuropeptides, Oncoproteins, Signaling Intermediates, Transcription Factors and Proteins Involved in Infectious D

Biomedical Technologies Incorporated

BTI Cell Growth Factors & Attachment Factors, BTI Immunoassay Kits, BTI Cell Culture Additives & Components, BTI Lipoproteins/Proteins, BTI Antibodies, BTI [I125] Labeled Compounds & Custom [I125] Radioiodinations.

Promedica International

Promedica International is a provider of CRO services to themedical device, biotech and pharmaceutical industries. Specializing in projectsinvolving innovative technology, our experienced staff and ISO-certified processesare the primary factors enabling us to consistently provide services highly regarded by our clients and their related study teams

ibt - immunological & biochemical testsystems GmbH

ibt - immunological and biochemical testsystems GmbH is a company dedicated to supply the scientific community with reagents and assays. Our reagents are recombinant proteins (viral and bacterial antigens, cytokines and chemokines, growth factors, hormones, transcription factors, tumor markers, enzymes and others) and polyclonal and monoclonal antibodies. Our main interest is in insulin-like grow...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

Mendel Biotechnology, Inc

Mendel Biotechnology was founded in early 1997 to develop the idea that controlling gene expression would create new opportunities to improve plant growth and development. We have focused on a large class of genes called transcription factors because they control the degree to which each gene in a cell is activated. The approximately 27,000 genes in the Arabidopsis genome are controlled by approxi...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

BioMed Capital Group Ltd.

BioMed principals and affiliates understand the strategic factors that drive future performance, including: Competition and competitive advantages Technology as related to markets served Capital requirements Value proposition BioMed incorporates thorough and well developed planning methods to identify critical factors, map out and identify strategic alternatives. Importantly, we are fully commit...

Multiplicom N.V.

Multiplicom produces molecular diagnostic kits that enable clinical laboratories to perform affordable testing for personalized medicine. The company was created in 2011 as a spin-off by the University of Antwerp and VIB. Multiplicom develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. The successful intro...

CompanionDx

With locations in Houston, Texas and Honolulu, Hawaii, CompanionDx™ Reference Lab is a high-complexity CLIA certified laboratory specializing in pharmacogenomics, cancer companion diagnostics, targeted NGS and epigenomics testing. CompanionDx™ is committed to the next evolution in cancer care where comprehensive genetic data is delivered in an ac...

i3 Statprobe

Because we're strong in every area, you can outsource an entire study to i3 Statprobe, or outsource, for example, only the statistical programming for a single study. Or you can outsource only the statistical programming for every study. Use us any way you want to, we encourage it. For example, we'll provide a dedicated team of specialists (say, data coordinators or statistical programmers) to wor...

Probably Relevant

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

Agilis Consulting Group,LLC

Agilis (from the Latin 'agile') helps clients in the medical industry achieve measurable results with higher customer satisfaction and profits. By carefully applying human factors and human performance principles to your market landscape, we help you differentiate yourself from the competition and attract customers by providing medical products that are safe and responsive to their needs.The FDA r...

Tyrogenex

Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.

GlobalCare Clinical Trials, Ltd

GlobalCare Clinical Trials, Ltd, is the leading global provider of ambulant healthcare services for clinical trials to government agencies and the world’s biopharmaceutical and medical device companies engaged in all phases of product development. GlobalCare provides innovative, GCP-compliant services by conducting selected study visits in the home or...

PharmaLinkFHI, Inc.

PharmaLink provides complete eClinical research services to support and streamline the drug development process. Clinical teams leverage real-time study information to make immediate decisions based on emerging trends and study issues. Our accelerated processes, centralized information management and global reach make it possible to conduct trials of any size or complexity from virtually anywhere....


More From BioPortfolio on "Study of Genetic Factors Other Than CYP2C9 and VKORC1 That Influence Warfarin Dose Requirements in a South-east Asian Population"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks